Infleqtion, Inc.
For the period ended Jun 30, 2026. Filed Aug 18, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 18, 2026
INFQ$9.35-3.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (unaudited)
Condensed Consolidated Statements of Cash Flows
(Unaudited; in thousands)
| Six Months Ended June 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities | ||
| Net loss | $(54,414) | $(15,005) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization expense | 1,928 | 1,555 |
| Stock-based compensation expense | 20,359 | 1,887 |
| Change in fair value of contingent obligation | 1,472 | — |
| Other non-cash operating adjustments | (2,429) | (807) |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 4,089 | 1,526 |
| Unbilled receivables | (850) | (522) |
| Inventories | (1,535) | (1,468) |
| Prepaid expenses and other current assets | (3,845) | 671 |
| Other assets | (75) | (37) |
| Accounts payable | (1,986) | 4,507 |
| Accrued liabilities | 35,234 | (2,731) |
| Contract liabilities | (4,283) | 994 |
| Operating lease right-of-use assets | 711 | 476 |
| Operating lease liabilities | (350) | (773) |
| Net cash used in operating activities | (5,974) | (9,727) |
| Cash flows from investing activities | ||
| Purchases of available-for-sale securities | (529,743) | — |
| Maturities of available-for-sale securities | 60,200 | — |
| Purchase of non-marketable equity investment | (3,000) | — |
| Purchases of property and equipment | (1,702) | (1,098) |
| Net cash used in investing activities | (474,245) | (1,098) |
| Cash flows from financing activities | ||
| Proceeds from issuance of Series C convertible redeemable preferred stock | — | 49,222 |
| Proceeds from stock options and warrant exercises | 4,729 | 784 |
| Payment of offering costs | (3,306) | — |
| Proceeds from Business Combination, net of redemptions | 528,166 | — |
| Payment of deferred cash consideration | (475) | (713) |
| Net cash provided by financing activities | 529,114 | 49,293 |
| Foreign currency translation | (370) | 1,187 |
| Net increase in cash and cash equivalents and restricted cash | $48,525 | $39,655 |
| Cash, cash equivalents and restricted cash at beginning of period | $11,894 | $48,142 |
| Cash, cash equivalents and restricted cash at end of period | $60,419 | $87,797 |
| Supplemental non-cash disclosure of cash flow information | ||
| Conversion of preferred stock to common stock | $(253,630) | $— |
| Reclassification of deferred offering costs in connection with business combination | $(9,298) | $— |
| Unpaid offering costs | $786 | $— |
| Unrealized gains or losses on available-for-sale securities | $(1,077) | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.